{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:27:33Z","timestamp":1792315653453,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Anxiety Disorders"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.janxdis.2019.102173","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T20:12:33Z","timestamp":1576008753000},"page":"102173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A systematic review of case studies testing a melatonergic agonist\/ 5HT2c antagonist for individuals with obsessive compulsive disorder"],"prefix":"10.1016","volume":"69","author":[{"given":"Meredith E.","family":"Coles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.janxdis.2019.102173_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/JCP.0000000000000659","article-title":"Intranasal ketamine and cognitive-behavioral therapy for treatment-refractory obsessive-compulsive disorder","volume":"37","author":"Adams","year":"2017","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102173_bib0010","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4088\/JCP.v68n0726a","article-title":"Bright light therapy for negative symptoms in schizophrenia: A pilot study","volume":"68","author":"Aichhorn","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102173_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1532-5415.2002.50060.x","article-title":"Effects of light treatment on sleep and circadian rhythms in demented nursing home patients","volume":"50","author":"Ancoli-Israel","year":"2002","journal-title":"Journal of American Geriatric Society"},{"key":"10.1016\/j.janxdis.2019.102173_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jocrd.2014.12.004","article-title":"Cost-effectiveness of internet-based cognitive behavior therapy for obsessive-compulsive disorder: Results from a randomized controlled trial","volume":"4","author":"Andersson","year":"2015","journal-title":"Journal of Obsessive-compulsive and Related Disorders"},{"issue":"13","key":"10.1016\/j.janxdis.2019.102173_bib0025","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1017\/S0033291714000543","article-title":"Long-term efficacy of Internet-based cognitive behavior therapy for obsessive\u2013Compulsive disorder with or without booster: A randomized controlled trial","volume":"44","author":"Andersson","year":"2014","journal-title":"Psychological Medicine"},{"issue":"10","key":"10.1016\/j.janxdis.2019.102173_bib0030","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/mp.2011.149","article-title":"Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels","volume":"17","author":"Baird","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102173_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/642752","article-title":"Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder : A case report","volume":"2012","author":"Berardis","year":"2012","journal-title":"Case Reports in Psychiatry"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102173_bib0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102173_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0165-0327(03)00003-X","article-title":"Symptoms of seasonal affective disorder and of obsessive-compulsive disorder reduced by light therapy","volume":"74","author":"Brinkhuijsen","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102173_bib0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1176\/ajp.142.7.811","article-title":"Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects","volume":"142","author":"Brown","year":"1985","journal-title":"The American Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.janxdis.2019.102173_bib0055","first-page":"1215","article-title":"A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression","volume":"19","author":"Claustrat","year":"1984","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/15402002.2011.634939","article-title":"Delayed bedtimes and obsessive \u2013 Compulsive symptoms","volume":"10","author":"Coles","year":"2012","journal-title":"Behavioral Sleep Medicine"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102173_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/JCSM.1080","article-title":"Compulsion or chronobiology? A case of severe obsessive-compulsive disorder treated with cognitive-behavioral therapy augmented with chronotherapy","volume":"7","author":"Coles","year":"2011","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/4.1.1","article-title":"Chronotherapy: Resetting the circadian clocks of patients with delayed sleep phase insomnia","volume":"4","author":"Czeisler","year":"1981","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/WNF.0b013e318223421f","article-title":"Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD","volume":"34","author":"da Rocha","year":"2011","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.janxdis.2019.102173_bib0080","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/NDT.S3149","article-title":"Current trends in drug treatment of obsessive-compulsive disorder","volume":"6","author":"Decloedt","year":"2010","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.janxdis.2019.102173_bib0085","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. (2000). Washington, DC: American Psychiatric Association Press."},{"key":"10.1016\/j.janxdis.2019.102173_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.janxdis.2017.03.006","article-title":"Sleep disturbances in obsessive-compulsive disorder: Association with non-response to repetitive transcranial magnetic stimulation (rTMS)","volume":"49","author":"Donse","year":"2017","journal-title":"Journal of Anxiety Disorders"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102173_bib0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2017.03.011","article-title":"Motor-activity markers of circadian timekeeping are related to ketamine\u2019s rapid antidepressant properties","volume":"82","author":"Duncan","year":"2017","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102173_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep08381","article-title":"Circadian rhythm phase shifts and endogenous free-running circadian period differ between African-Americans and European-Americans","volume":"5","author":"Eastman","year":"2015","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/j.janxdis.2019.102173_bib0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.brat.2004.11.007","article-title":"How effective are cognitive and behavioral treatments for obsessive\u2013compulsive disorder? A clinical significance analysis","volume":"43","author":"Fisher","year":"2005","journal-title":"Behaviour Research and Therapy"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0110","doi-asserted-by":"crossref","DOI":"10.1186\/1744-859X-10-5","article-title":"Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: A 3 month follow-up case series","volume":"10","author":"Fornaro","year":"2011","journal-title":"Annals of General Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2869.2008.00635.x","article-title":"Relationships between affect, vigilance, and sleepiness following sleep deprivation","volume":"17","author":"Franzen","year":"2008","journal-title":"Journal of Sleep Research"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09291016.2011.638137","article-title":"Circadian rhythms in two components of executive functions: Cognitive inhibition and flexibility","volume":"43","author":"Garc\u00eda","year":"2012","journal-title":"Biological Rhythm Research"},{"issue":"6","key":"10.1016\/j.janxdis.2019.102173_bib0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopsych.2005.07.006","article-title":"Light therapy for Seasonal Affective Disorder with blue narrow-band light-emitting diodes (LEDs)","volume":"59","author":"Glickman","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1176\/appi.ajp.162.4.656","article-title":"The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence","volume":"162","author":"Golden","year":"2005","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102173_bib0135","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1176\/appi.ajp.2008.08010098","article-title":"Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation","volume":"165","author":"Harvey","year":"2008","journal-title":"The American Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.janxdis.2019.102173_bib0140","first-page":"701","article-title":"Successful treatment of seasonal compulsive syndrome with phototherapy","volume":"63","author":"Hoflich","year":"1992","journal-title":"Der Nervenarzt"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102173_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola","year":"2015","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.comppsych.2009.10.001","article-title":"Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder","volume":"51","author":"Koran","year":"2010","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102173_bib0155","first-page":"1","article-title":"Circadian rhythms in obsessive\u2013compulsive disorder","author":"Lange","year":"2012","journal-title":"Journal of Neural Transmission"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102173_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw003","article-title":"Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms","volume":"19","author":"Martinotti","year":"2016","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102173_bib0165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psychres.2008.05.007","article-title":"The Maudsley Obsessive-Compulsive Stimuli set: Validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder","volume":"168","author":"Mataix-Cols","year":"2009","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1213\/ANE.0b013e3182632bcb","article-title":"Day or night administration of ketamine and pentobarbital differentially affect circadian rhythms of pineal melatonin secretion and locomotor activity in rats","volume":"115","author":"Mihara","year":"2012","journal-title":"Anesthesia and Analgesia"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102173_bib0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2017.07.005","article-title":"Ketamine and sleep: Bridging the gap in the treatment of depressive illness","volume":"82","author":"Morgan","year":"2017","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1016\/j.janxdis.2019.102173_bib0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1017\/S1092852900016576","article-title":"Delayed sleep phase in severe obsessive-compulsive disorder: A systematic case-report survey","volume":"13","author":"Mukhopadhyay","year":"2008","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.janxdis.2019.102173_bib0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neubiorev.2015.01.002","article-title":"Sleep, arousal, and circadian rhythms in adults with obsessive-compulsive disorder: A meta-analysis","volume":"51","author":"Nota","year":"2015","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102173_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145702002900","article-title":"Treatment non-response in OCD: Methodological issues and operational definitions","volume":"5","author":"Pallanti","year":"2002","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.janxdis.2019.102173_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.beth.2017.09.003","article-title":"Acceptability, feasibility, and effectiveness of internet-based cognitive-behavioral therapy for obsessive-compulsive disorder in New York","volume":"49","author":"Patel","year":"2018","journal-title":"Behavior Therapy"},{"issue":"10","key":"10.1016\/j.janxdis.2019.102173_bib0200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/14656566.2014.914493","article-title":"An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder","volume":"15","author":"Pizarro","year":"2014","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.janxdis.2019.102173_bib0205","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archpsyc.1984.01790120076010","article-title":"Seasonal Affective Disorder: a description of the syndrome and preliminary findings with light therapy","volume":"41","author":"Rosenthal","year":"1984","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.janxdis.2019.102173_bib0215","doi-asserted-by":"crossref","DOI":"10.1177\/2050313X14561778","article-title":"Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors","volume":"2","author":"Signorelli","year":"2014","journal-title":"SAGE Open Medical Case Reports"},{"issue":"2","key":"10.1016\/j.janxdis.2019.102173_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archpsyc.56.2.121","article-title":"A 40-Year follow-up of patients with obsessive-compulsive disorder","volume":"56","author":"Skoog","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.janxdis.2019.102173_bib0225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-1781(89)90207-2","article-title":"Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality","volume":"28","author":"Soutre","year":"1989","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102173_bib0230","first-page":"708","article-title":"Defining treatment response and remission in obsessive-compulsive disorder: A signal detection analysis of the children\u2019s yale-brown obsessive compulsive scale","volume":"49","author":"Storch","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1016\/j.janxdis.2019.102173_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0893-133X(89)90002-X","article-title":"Light therapy for SAD: A review of efficacy","volume":"2","author":"Terman","year":"1989","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.janxdis.2019.102173_bib0240","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.euroneuro.2016.03.001","article-title":"Light therapy in the treatment of patients with bipolar depression: A meta-analytic study","volume":"26","author":"Tseng","year":"2016","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.janxdis.2019.102173_bib0245","first-page":"108","article-title":"A prospective study of delayed sleep phase syndrome in patients with severe resistant obsessive-compulsive disorder","volume":"6","author":"Turner","year":"2007","journal-title":"World Psychiatry"},{"issue":"7","key":"10.1016\/j.janxdis.2019.102173_bib0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1981.01780320017001","article-title":"Delayed sleep phase syndrome: A chronobiological disorder with sleep-onset insomnia","volume":"38","author":"Weitzman","year":"1981","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Anxiety Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618519304992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887618519304992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:11:09Z","timestamp":1760137869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887618519304992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":50,"alternative-id":["S0887618519304992"],"URL":"https:\/\/doi.org\/10.1016\/j.janxdis.2019.102173","relation":{},"ISSN":["0887-6185"],"issn-type":[{"value":"0887-6185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of case studies testing a melatonergic agonist\/ 5HT2c antagonist for individuals with obsessive compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Anxiety Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.janxdis.2019.102173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102173"}}